Nanotechnology-Driven Delivery Systems in Inoculation Therapies-Reference-Cited by-同舟云学术

Nanotechnology-Driven Delivery Systems in Inoculation Therapies

Published:2022-10-28 Issue: Volume: Page:39-57
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Pereira Glaucia C.

Publisher

Springer US

Link

https://link.springer.com/content/pdf/10.1007/978-1-0716-2716-7_3

Reference87 articles.

1. Pereira GC (2020) Governing issues in nanoscale systems and their potential for improving the therapeutic application of phytoconstituents. In: Swamy MK, Saeed M (eds) Plant-derived bioactives - chemistry and mode of action. Springer Nature

2. Sahin U, Karikó K (2014) Türeci Ö (2014) mRNA-based therapeutics — developing a new class of drugs. Nat Rev Drug Discov 1310(13):759–780. https://doi.org/10.1038/nrd4278

3. Veber DF, Johnson SR, Cheng H-Y et al (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615–2623. https://doi.org/10.1021/jm020017n

4. Lin JH, Yamazaki M (2003) Role of P-glycoprotein in pharmacokinetics. Clin Pharmacokinet 42:59–98. https://doi.org/10.2165/00003088-200342010-00003

5. Khojasteh SC, Wong H, Hop CECA (2011) Pharmacokinetics. In: Drug metabolism and pharmacokinetics quick guide. Springer New York, New York, pp 1–15

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel degradable PEG superparamagnetic iron oxide capsule coupled with a polyphenolic nano-enzymatic conjugate (PSPM-NE), to treat ROS-driven cardiovascular-diseases, tested in atherosclerosis as a model disease, and hypothesizing autoimmunity as an atheroma's trigger;Frontiers in Cardiovascular Medicine;2024-07-02